Credit Agricole’s Scinai Immunotherapeutics SCNI Stock Holding History

Credit Agricole’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$113	Hold	42	–	–	﹤0.01%	1259
2024 Q4	$140	Hold	42	–	–	﹤0.01%	1268
2024 Q3	$145	Hold	42	–	–	﹤0.01%	1270
2024 Q2	$117	Hold	42	–	–	﹤0.01%	1096
2024 Q1	$193	Hold	42	–	–	﹤0.01%	932
2023 Q4	$252	Buy	+42	New	+$289	﹤0.01%	895
2023 Q3	–	Sell	-42	Closed	-$598	–	972
2023 Q2	$598	Hold	42	–	–	﹤0.01%	675
2023 Q1	$916	Hold	42	–	–	﹤0.01%	638
2022 Q4	$1.25K	Hold	42	–	–	﹤0.01%	675
2022 Q3	$3K	Hold	42	–	–	﹤0.01%	645
2022 Q2	$5K	Hold	42	–	–	﹤0.01%	637
2022 Q1	$7K	Hold	42	–	–	﹤0.01%	652
2021 Q4	$10K	Hold	42	–	–	﹤0.01%	640
2021 Q3	$9K	Hold	42	–	–	﹤0.01%	624
2021 Q2	$12K	Hold	42	–	–	﹤0.01%	599
2021 Q1	$16K	Buy	+42	New	+$18.3K	﹤0.01%	549

Other funds holding SCNI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Agricole's SCNI Position: Q1 2025 in Review

Credit Agricole held its Scinai Immunotherapeutics (SCNI) position steady in Q1 2025 at 42 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Credit Agricole first reported a position in SCNI in Q1 2021 and has held it in 16 quarters since. The position peaked at $16K in Q1 2021. 4 funds tracked by Wall St. Rank hold SCNI as of Q1 2025.

Credit Agricole held 42 shares of Scinai Immunotherapeutics worth $113 as of Q1 2025.
Credit Agricole left its Scinai Immunotherapeutics share count unchanged in Q1 2025.
Scinai Immunotherapeutics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1259 holding.
Credit Agricole first reported a position in Scinai Immunotherapeutics in Q1 2021 and has held it in 16 quarters since.
Credit Agricole's Scinai Immunotherapeutics position peaked at $16K in Q1 2021.
4 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.